Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.319 USD | +2.74% | +4.25% | +3.24% |
Financials (USD)
Sales 2024 * | 15.62M | Sales 2025 * | 30.24M | Capitalization | 31.23M |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | -9M | EV / Sales 2024 * | 2 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.03 x |
P/E ratio 2024 * |
-1.94
x | P/E ratio 2025 * |
-3.73
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.35% |
Latest transcript on Daré Bioscience, Inc.
1 day | +1.77% | ||
1 week | +4.25% | ||
Current month | +3.74% | ||
1 month | -33.56% | ||
3 months | -8.91% | ||
6 months | -8.62% | ||
Current year | +3.24% |
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 14-12-31 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 14-12-31 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19-11-19 |
Chairman | 76 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 0.319 | +2.74% | 91 020 |
24-05-10 | 0.3105 | -0.99% | 233,859 |
24-05-09 | 0.3136 | +2.12% | 134,810 |
24-05-08 | 0.3071 | -0.94% | 225,768 |
24-05-07 | 0.31 | +1.31% | 182,693 |
Delayed Quote Nasdaq, May 13, 2024 at 12:27 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.24% | 31.23M | |
+23.74% | 44.96B | |
+0.32% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+10.73% | 26.08B | |
-21.18% | 19.03B | |
+6.58% | 12.75B | |
+29.23% | 12.06B | |
-3.33% | 11.75B |
- Stock Market
- Equities
- DARE Stock